|
ACE/Angiotension receptors
Citations 541-550 of 995 total displayed.
|
Past content
(since Jan 1999):
|
- Brief Reviews
Transcriptional Regulation of Renin. An Update
- Li Pan and Kenneth W. Gross
Hypertension published November 15, 2004, doi:10.1161/01.HYP.0000149717.55920.45
[Abstract]
- Rapid Communications
Angiotensin-(1-7) Attenuates Neointimal Formation After Stent Implantation in the Rat
- Bas Langeveld, Wiek H. van Gilst, René A. Tio, Felix Zijlstra, and Anton J.M. Roks
Hypertension published November 15, 2004, doi:10.1161/01.HYP.0000149382.83973.c2
[Abstract]
- Scientific Contributions
Angiotensin Subtype-2 Receptors Inhibit Renin Biosynthesis and Angiotensin II Formation
- Helmy M. Siragy, Chun Xue, Peter Abadir, and Robert M. Carey
Hypertension published November 8, 2004, doi:10.1161/01.HYP.0000149105.75125.2a
[Abstract]
- Editorial Commentary
Osteopontin: A Protective Mediator of Cardiac Fibrosis?
- Kristof Graf and Philipp Stawowy
Hypertension published November 1, 2004, doi:10.1161/01.HYP.0000148459.25908.49
[Abstract]
- Brief Reviews
Pathophysiology of Hypertensive Renal Damage: Implications for Therapy
- Anil K. Bidani and Karen A. Griffin
Hypertension 2004;44:595-601; published online before print as doi:10.1161/01.HYP.0000145180.38707.84
[Abstract]
[Full text]
- Editorial Commentaries
Peroxisome ProliferatorActivated Receptors Ligands, Oxidative Stress, and Cardiac Fibroblast Extracellular Matrix Turnover
- Francisco J. Villarreal and Juan Asbun
Hypertension 2004;44:621-622; published online before print as doi:10.1161/01.HYP.0000144401.18602.67
[Full text]
- Scientific Contributions
Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts: Modulation by PPAR- Ligand Pioglitazone
- Kui Chen, Jiawei Chen, Dayuan Li, Xingjian Zhang, and Jawahar L. Mehta
Hypertension 2004;44:655-661; published online before print as doi:10.1161/01.HYP.0000144400.49062.6b
[Abstract]
[Full text]
- Scientific Contributions
NO Synthase Inhibition Increases Aldosterone in Humans
- James A.S. Muldowney, III, Stephen N. Davis, Douglas E. Vaughan, and Nancy J. Brown
Hypertension 2004;44:739-745; published online before print as doi:10.1161/01.HYP.0000143852.48258.f1
[Abstract]
[Full text]
- Scientific Contributions
Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis
- Zhen Li, Masaru Iwai, Lan Wu, Hong-Wei Liu, Rui Chen, Toyohisa Jinno, Jun Suzuki, Masahiro Tsuda, Xin-Yu Gao, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension 2004;44:758-763; published online before print as doi:10.1161/01.HYP.0000145179.44166.0f
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin-(17) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats
- Mariela M. Gironacci, María S. Valera, Irene Yujnovsky, and Clara Peña
Hypertension 2004;44:783-787; published online before print as doi:10.1161/01.HYP.0000143850.73831.9d
[Abstract]
[Full text]
|
|